Bicara Therapeutics Inc (BCAX)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Ivan HyepCFO & Treasurer | -9.20k | 153.02k | Derivative Exercise and Sale | 3.79 - 20.42 | 145.36k | - |
| 2026-05-18 | Dr. Claire Mazumdar ClemonCEO & Director | -15.00k | 243.73k | Derivative Exercise and Sale | 3.79 - 20.35 | 362.15k | - |
| 2026-05-15 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 91.31k | Automatic Disposition | 20.29 | 191.64k | -2.29% |
| 2026-05-15 | Mr. Ryan CohlheppPresident, COO & Director | -8.00k | 132.02k | Derivative Exercise and Sale | 3.79 - 20.29 | 191.64k | - |
| 2026-04-27 | Dr. David Rabenインサイダー | -5.50k | 104.99k | Derivative Exercise and Sale | 3.79 - 22.88 | 55.29k | - |
| 2026-04-21 | Mr. Ivan HyepCFO & Treasurer | -9.20k | 176.75k | Derivative Exercise and Sale | 3.79 - 23.00 | 145.36k | - |
| 2026-04-20 | Dr. Claire Mazumdar ClemonCEO & Director | -15.00k | 297.30k | Derivative Exercise and Sale | 3.79 - 23.61 | 362.15k | - |
| 2026-04-16 | Dr. Claire Mazumdar ClemonCEO & Director | 22.76k | 103.36k | Derivative Exercise and Retained Stock | 3.79 - 5.45 | 362.15k | 6.71% |
| 2026-04-15 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 103.53k | Automatic Disposition | 23.01 | 196.14k | -2.24% |
| 2026-04-15 | Mr. Ryan CohlheppPresident, COO & Director | -8.00k | 153.74k | Derivative Exercise and Sale | 3.79 - 23.01 | 196.14k | - |
| 2026-03-25 | Dr. David Rabenインサイダー | -5.50k | 83.39k | Derivative Exercise and Sale | 3.79 - 18.95 | 55.29k | - |
| 2026-03-23 | Mr. Ivan HyepCFO & Treasurer | -9.20k | 135.48k | Derivative Exercise and Sale | 3.79 - 18.52 | 145.36k | - |
| 2026-03-18 | Dr. Claire Mazumdar ClemonCEO & Director | -15.00k | 225.52k | Derivative Exercise and Sale | 3.79 - 18.95 | 339.39k | - |
| 2026-03-16 | Mr. Ryan CohlheppPresident, COO & Director | -8.00k | 126.94k | Derivative Exercise and Sale | 3.79 - 19.66 | 200.64k | - |
| 2026-03-16 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 88.46k | Automatic Disposition | 19.66 | 200.64k | -2.19% |
| 2026-03-09 | Dr. Claire Mazumdar ClemonCEO & Director | -36.77k | 565.32k | Derivative Exercise and Sale | 3.79 - 19.17 | 339.39k | - |
| 2026-03-04 | Dr. Claire Mazumdar ClemonCEO & Director | -8.23k | 123.12k | Derivative Exercise and Sale | 3.79 - 18.75 | 339.39k | - |
| 2026-03-03 | Mr. Ryan CohlheppPresident, COO & Director | -12.89k | 185.30k | Derivative Exercise and Sale | 3.79 - 18.16 | 205.14k | - |
| 2026-03-03 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 81.73k | Automatic Disposition | 18.16 | 205.14k | -2.15% |
| 2026-03-03 | Mr. Ivan HyepCFO & Treasurer | -16.52k | 238.37k | Derivative Exercise and Sale | 3.79 - 18.25 | 145.36k | - |
| 2026-03-03 | Dr. David Rabenインサイダー | -16.50k | 243.08k | Derivative Exercise and Sale | 3.79 - 18.52 | 55.29k | - |
| 2026-02-26 | RA Capital Management, L.P.法人 | 300.00k | 4.80M | 買い | 16.00 | 4.60M | 6.97% |
| 2026-02-26 | RA Capital Management, L.P.法人 | 2.20M | 0.00 | Open Market Derivative Acquisition | 0.00 | 2.20M | - |
| 2026-02-25 | Mr. Ryan CohlheppPresident, COO & Director | -3.11k | 44.29k | Derivative Exercise and Sale | 3.79 - 18.04 | 209.64k | - |
| 2026-02-25 | Mr. Ryan CohlheppPresident, COO & Director | -523.00 | 9.43k | Automatic Disposition | 18.04 | 209.64k | -0.25% |
| 2026-01-22 | Mr. Ryan CohlheppPresident, COO & Director | -3.83k | 69.30k | Automatic Disposition | 18.10 | 210.16k | -1.79% |
| 2026-01-22 | Mr. Ivan HyepCFO & Treasurer | -1.88k | 27.03k | Derivative Exercise and Sale | 3.79 - 18.15 | 145.36k | - |
| 2026-01-15 | Mr. Ryan CohlheppPresident, COO & Director | -149.00 | 2.68k | Automatic Disposition | 18.02 | 213.99k | -0.07% |
| 2025-12-26 | Mr. Ryan CohlheppPresident, COO & Director | 25.00k | 110.92k | Derivative Exercise and Retained Stock | 4.44 | 214.14k | 13.22% |
| 2025-12-26 | Dr. David Rabenインサイダー | 19.79k | 75.00k | Derivative Exercise and Retained Stock | 3.79 | 55.29k | 55.75% |
| 2025-12-22 | Mr. Ivan HyepCFO & Treasurer | -9.20k | 133.63k | Derivative Exercise and Sale | 3.79 - 18.31 | 145.36k | - |
| 2025-12-16 | Dr. Claire Mazumdar ClemonCEO & Director | 29.50k | 160.88k | Derivative Exercise and Retained Stock | 5.45 | 339.39k | 9.52% |
| 2025-12-15 | Mr. Ryan CohlheppPresident, COO & Director | -8.00k | 119.15k | Derivative Exercise and Sale | 3.79 - 18.68 | 189.14k | - |
| 2025-12-15 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 84.08k | Automatic Disposition | 18.68 | 189.14k | -2.32% |
| 2025-11-21 | Mr. Ryan CohlheppPresident, COO & Director | -8.00k | 114.06k | Derivative Exercise and Sale | 3.79 - 18.05 | 193.64k | - |
| 2025-11-21 | Mr. Ryan CohlheppPresident, COO & Director | -4.50k | 81.21k | Automatic Disposition | 18.05 | 193.64k | -2.27% |
| 2025-11-21 | Mr. Ivan HyepCFO & Treasurer | -18.40k | 271.34k | Derivative Exercise and Sale | 3.79 - 18.55 | 145.36k | - |
| 2025-11-24 | Dr. Claire Mazumdar ClemonCEO & Director | -41.16k | 620.43k | Derivative Exercise and Sale | 3.79 - 18.86 | 309.89k | - |
| 2025-11-24 | Dr. David Rabenインサイダー | -11.00k | 163.42k | Derivative Exercise and Sale | 3.79 - 18.84 | 35.50k | - |
| 2025-10-16 | Dr. Claire Mazumdar ClemonCEO & Director | -24.10k | 362.42k | Derivative Exercise and Sale | 3.79 - 18.83 | 309.89k | - |
| 2025-10-13 | Dr. Claire Mazumdar ClemonCEO & Director | -24.73k | 373.20k | Derivative Exercise and Sale | 3.79 - 18.92 | 309.89k | - |
| 2025-10-09 | Mr. Ivan HyepCFO & Treasurer | -6.42k | 92.62k | Derivative Exercise and Sale | 3.79 - 18.23 | 145.36k | - |
| 2025-10-09 | Dr. David Rabenインサイダー | -22.00k | 322.52k | Derivative Exercise and Sale | 3.79 - 18.45 | 35.50k | - |
| 2025-10-06 | Mr. Ivan HyepCFO & Treasurer | -30.39k | 438.05k | Derivative Exercise and Sale | 3.79 - 18.22 | 145.36k | - |
| 2025-10-06 | Mr. Ryan CohlheppPresident, COO & Director | -32.00k | 456.53k | Derivative Exercise and Sale | 3.79 - 18.06 | 202.64k | - |
| 2025-10-06 | Mr. Ryan CohlheppPresident, COO & Director | -18.50k | 334.04k | Automatic Disposition | 18.06 | 202.64k | -8.37% |
| 2025-09-29 | Ms. Lara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary | -33.81k | 186.16k | Derivative Exercise and Sale | 9.24 - 14.75 | 0.00 | - |
| 2025-09-15 | Ms. Lara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary | -15.83k | 95.61k | Derivative Exercise and Sale | 5.45 - 11.49 | - | - |
| 2025-06-16 | Ms. Lara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary | -15.83k | 78.83k | Derivative Exercise and Sale | 5.45 - 10.43 | 0.00 | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。